Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment
Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment
Recruiting · NCT07708727 · Registry updated 2026-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment | HIV-1-infection | Recruiting | Phase 2 / Phase 3 | 2026-09-09 | NCT07708727 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gilead Sciences | 180 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| HOPE Clinical Research | San Juan | Puerto Rico | 6 |
| KC CARE Health Center | Kansas City | United States | 8 |
| McGill University Health Centre | Montreal | Canada | 69 |
| Metro Infectious Disease Consultants, P.L.L.C | Decatur | United States | 1 |
| Midway Immunology and Research Center | Ft. Pierce | United States | 11 |
| North Texas Infectious Diseases Consultants, PA | Dallas | United States | 4 |
| Orlando Immunology Center, PA | Florida City | United States | 1 |
| Prism Health North Texas | Dallas | United States | 2 |
| St Hope Foundation, Inc, | Bellaire | United States | 1 |
| Texas Centers for Infectious Disease Associates | Fort Worth | United States | 2 |
| Triple O Research Institute, P.A. | West Palm Beach | United States | 3 |